Location History:
- Washington, DC (US) (1988 - 1990)
- Glencoe, IL (US) (1991)
Company Filing History:
Years Active: 1988-1991
Title: Martha C Farmer: Innovator in Blood Substitute Technology
Introduction
Martha C Farmer is a distinguished inventor based in Washington, DC. She has made significant contributions to the field of medical technology, particularly in the development of blood substitutes. With a total of 3 patents, her work has the potential to revolutionize transfusion medicine.
Latest Patents
One of her latest patents focuses on the preservation and restoration of hemoglobin in blood substitutes. This innovative preparation protects hemoglobin from oxidation to methemoglobin. The formulation includes compounds such as glutathione, nicotinamide adenine dinucleotide, and nicotine adenine dinucleotide phosphate, which are crucial for maintaining the stability of hemoglobin in blood products. Another notable patent involves a blood substitute comprising liposome-encapsulated hemoglobin. This sterile preparation boasts an oxygen-carrying capacity of 20 vol% and a half-life of 15-20 hours in mice, showcasing its potential efficacy in clinical applications.
Career Highlights
Martha C Farmer is currently associated with the United States Navy, where she contributes her expertise in medical innovations. Her work is instrumental in advancing the field of blood substitutes, which can address critical shortages in blood supply during emergencies and surgeries.
Collaborations
Martha has collaborated with notable colleagues such as Richard L Beissinger and Lewis P Stratton. These partnerships have fostered a collaborative environment that enhances the development of innovative medical solutions.
Conclusion
Martha C Farmer's contributions to blood substitute technology exemplify her commitment to improving medical care. Her innovative patents and collaborations position her as a key figure in the advancement of transfusion medicine.